Correlation Between ABIVAX Socit and GeneThera
Can any of the company-specific risk be diversified away by investing in both ABIVAX Socit and GeneThera at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABIVAX Socit and GeneThera into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABIVAX Socit Anonyme and GeneThera, you can compare the effects of market volatilities on ABIVAX Socit and GeneThera and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABIVAX Socit with a short position of GeneThera. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABIVAX Socit and GeneThera.
Diversification Opportunities for ABIVAX Socit and GeneThera
-1.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between ABIVAX and GeneThera is -1.0. Overlapping area represents the amount of risk that can be diversified away by holding ABIVAX Socit Anonyme and GeneThera in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneThera and ABIVAX Socit is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABIVAX Socit Anonyme are associated (or correlated) with GeneThera. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneThera has no effect on the direction of ABIVAX Socit i.e., ABIVAX Socit and GeneThera go up and down completely randomly.
Pair Corralation between ABIVAX Socit and GeneThera
If you would invest 0.01 in GeneThera on September 14, 2024 and sell it today you would earn a total of 0.00 from holding GeneThera or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Strong |
Accuracy | 95.45% |
Values | Daily Returns |
ABIVAX Socit Anonyme vs. GeneThera
Performance |
Timeline |
ABIVAX Socit Anonyme |
GeneThera |
ABIVAX Socit and GeneThera Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ABIVAX Socit and GeneThera
The main advantage of trading using opposite ABIVAX Socit and GeneThera positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABIVAX Socit position performs unexpectedly, GeneThera can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneThera will offset losses from the drop in GeneThera's long position.ABIVAX Socit vs. Advanced Proteome Therapeutics | ABIVAX Socit vs. Oxford BioDynamics Plc | ABIVAX Socit vs. GeneThera | ABIVAX Socit vs. ChitogenX |
GeneThera vs. Rigel Pharmaceuticals | GeneThera vs. Geron | GeneThera vs. Verastem | GeneThera vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
CEOs Directory Screen CEOs from public companies around the world | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |